Arantzazu Barquin
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Multicenter study correlating molecular characteristics and clinical outcomes of cancer cases with patient-derived organoids.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 12, 2025
The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 27, 2024
Phase II clinical trial assessing the efficacy of enzalutamide in advanced non-resectable granulosa cell ovarian tumors: The GREKO III study (GETHI2016-01).
Journal: Gynecologic oncology
Published: September 18, 2024
Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer.
Journal: The Journal of clinical investigation
Published: October 04, 2023
Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution.
Journal: Frontiers in immunology
Published: February 01, 2023
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 01, 2022
MEK inhibitor sensitivity in BRAF fusion-driven prostate cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: June 13, 2022
Huge recurrent gastric neuroendocrine tumor: a second-line chemotherapeutic dilemma.
Journal: Autopsy & case reports
Published: September 25, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026